We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Phase II Trial of Combination Therapy With S-1, Irinotecan, and Bevacizumab (SIRB) in Patients With Unresectable or Recurrent Colorectal Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00569335
Recruitment Status : Completed
First Posted : December 7, 2007
Last Update Posted : November 2, 2012
Information provided by (Responsible Party):
Taiho Pharmaceutical Co., Ltd.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : March 2010
  Study Completion Date : March 2010